Reply to "Treatment of alcohol use disorders in patients with liver disease"

被引:1
作者
Addolorato, Giovanni [1 ]
Mirijello, Antonio [1 ,2 ]
Barrio, Pablo
Gual, Antoni [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Internal Med Gastroenterol & Hepatol, Alcohol Use Disorders Unit, Rome, Italy
[2] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, San Giovanni Rotondo, FG, Italy
[3] Hosp Clin Barcelona, IDIBAPS, Dept Psychiat, Neurosci Inst, Barcelona, Spain
关键词
DEPENDENCE; NALMEFENE; EFFICACY;
D O I
10.1016/j.jhep.2016.08.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1271 / 1271
页数:1
相关论文
共 6 条
  • [1] Treatment of alcohol use disorders in patients with alcoholic liver disease
    Addolorato, Giovanni
    Mirijello, Antonio
    Barrio, Pablo
    Gual, Antoni
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 618 - 630
  • [2] [Anonymous], 2015, BIOMED RES INT
  • [3] A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
    Gual, Antoni
    He, Yuan
    Torup, Lars
    van den Brink, Wim
    Mann, Karl
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (11) : 1432 - 1442
  • [4] Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
    Mann, Karl
    Bladstroem, Anna
    Torup, Lars
    Gual, Antoni
    van den Brink, Wim
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (08) : 706 - 713
  • [5] Pharmacotherapy for Alcohol Use Disorder: Current and Emerging Therapies
    Swift, Robert M.
    Aston, Elizabeth R.
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2015, 23 (02) : 122 - 133
  • [6] Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study
    van den Brink, Wim
    Sorensen, Per
    Torup, Lars
    Mann, Karl
    Gual, Antoni
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (08) : 733 - 744